Disclaimer

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions



DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?

SJM-CV WEB-0718-0009

/content/bss/divisionalsites/livesites/reusable/cv-livesite/us/en/pages/home
30
CARDIOVASCULAR
hamburger
BACK
About TactiCath
About

Ablate Efficiently with Predictability and Confidence

The first and only contact force catheter with a flexible tip.

Designed for optimal safety and stability, confident lesion creation and procedural efficiency,4 the TactiFlex™ Ablation Catheter, Sensor Enabled™ elevates ablation procedures through:

  • A proprietary tip design and full integration with the revolutionary EnSite™ X EP System
  • Enhanced tip stability2 during ablation and excellent signal quality and directed irrigation flow to the tissue-tip interface for safe lesion formation
  • Support predictability with intuitive contact force arrow and deflection direction indicator available with the EnSite X EP System

TactiFlex Ablation Catheter, Sensor Enabled Technology Animation

See a simulation of the flexible tip, stability and contact force measurement through fiber-optic technology.

TactiFlex

Perform High-Power Ablation* with Safety and Stability, Confidence and Efficiency

Designed for Optimal Safety and Stability

  • Apply directed irrigation flow1 to the tip-tissue interface, effectively cooling tissue for safe transmural ablation
  • Lower irrigation rate** while ablating up to 50W to reduce fluid loading for added safety4
  • Experience superior stability with a unique, flexible, laser-cut tip - up to 2X greater stability than conventional 56-hole catheters2


Confident Lesion Creation

  • Ablate with the proven performance of the Abbott contact force platform3
  • Optimize contact force measurement through fiber-optic technology
  • High resolution (1g) real-time (50Hz) force display with thermal compensation and no interference from other catheters


Procedural Efficiency4 from intuitive handling and usability with full EnSite X EP System integration

  • Reduce PVI ablation times by as much as 70%*** with high-power short-duration ablation5
  • Usability and predictability with intuitive contact force arrow and deflection direction indicator6
  • Monitor lesion creation with excellent electrogram signal quality even during RF7


Lesion Creation in the Heart
Ensite™ X EP System

  • Manuals & Resources
    Manuals & Resources
    Search
  • Reimbursement & Coding
    Reimbursement & Coding
    Find
  • Related Products
    Related Products
    See More

This device is commercially available for use in select international markets.

*Up to 50W
** Compared to TactiCath SE flow rates
*** Compared to standard power ablation (50W vs. 30W)

References

  1. Abbott report 90906650.
  2. Ambrosius Nick, Fish Jeffrey, Tranter John, Abbott Laboratories. Flexible, kerfed ablation catheter tip provides superior stability in a bench model [abstract]. In: APHRS 2018: Abstract Book; 2018, October 17-18; Taipei, Taiwan. Abstract nr 1170.
  3. Same contact force technology as in TactiCath Quartz and TactiCath SE, Abbott report 90702721.
  4. Nair, D., Martinek, M., Colley, J., et al. (2022). Acute Results of a Novel Flexible Tip Radiofrequency Catheter Incorporating Contact Force Sensing. EP Europace. 24(Supplement_1), i115-i116. https://doi.org/10.1093/europace/euac053.077
  5. Ptaszek LM et al. Safe and effective delivery of high-power, short-duration radiofrequency ablation lesions with a novel, flexible-tip radiofrequency ablation catheter [abstract]. In: Heart Rhythm 2021: July 28-31, Boston. Heart Rhythm Volume 18, Issue 9, Supplement. Elsevier; 2021. Abstract nr B-PO02-109.
  6. Compared to TactiCath SE and EnSite Precision™. Abbott reports 90486839 and 90773365.
  7. Abbott report 90486839.
Indications, Safety & Warnings

MAT-2208526 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

YESNO
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

The following content is intended for Healthcare Professionals except for those in France. Some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.



Si vous êtes un professionnel de santé exerçant en France ou dans les territoires Français, veuillez visiter notre site en français.



Do you want to continue? 

YesNo